RBC Capital Initiates Coverage On BeiGene with Outperform Rating, Announces Price Target of $259
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Jake Lynch has initiated coverage on BeiGene (NASDAQ:BGNE) with an Outperform rating and a price target of $259.
September 12, 2023 | 9:56 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
BeiGene has received an Outperform rating from RBC Capital, with a price target of $259.
The Outperform rating from RBC Capital indicates a positive outlook for BeiGene. The price target of $259 suggests a significant upside potential from the current price. This could lead to increased investor interest and potentially a rise in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100